Non-Approvable Letter

April 25, 2022

A second trip-up makes Axsome look careless

April 04, 2022

US FDA approval tracker: March

March 31, 2022

Akebia’s vadadustat knockback increases class doubts

March 28, 2022

Why some biotechs should never launch a drug

Acacia just became the latest biotech to suffer the curse of seeing one of its drugs approved.

March 02, 2022

US FDA approval tracker: February

February 01, 2022

US FDA approval tracker: January

January 05, 2022

US FDA approval tracker: December

December 01, 2021

US FDA approval tracker: November

November 01, 2021

US FDA approval tracker: October